Form 4: Soligenix Director Acquires Stock Options
SEC Form 4 Filing
Soligenix director Jerome B. Zeldis acquired 8,646 stock options on December 12, 2024, which vest over the next year.
Summary
- Jerome B. Zeldis, a director at Soligenix, Inc., acquired 8,646 stock options on December 12, 2024.
- The options have an exercise price of $3.47.
- These options vest ratably on March 12, 2025, June 12, 2025, September 12, 2025, and December 12, 2025.
- The options expire on December 12, 2034.
Sentiment
Score: 6
Explanation: The document is neutral, detailing a routine stock option grant. It is neither particularly positive nor negative from an investment perspective.
Positives
- The acquisition of stock options by a director could indicate confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.
Comparison to Industry Standards
- Stock option grants to directors are a common practice in publicly traded companies as part of their compensation and incentive programs.
- The vesting schedule of the options is typical, with vesting occurring over a period of time to align the director's interests with the long-term performance of the company.
- The exercise price of $3.47 is a standard feature of stock options, representing the price at which the director can purchase the underlying shares.
Stakeholder Impact
- The stock option grant could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/12/2024 | Date of stock option acquisition and grant. |
| 03/12/2025 | First vesting date of the stock options. |
| 06/12/2025 | Second vesting date of the stock options. |
| 09/12/2025 | Third vesting date of the stock options. |
| 12/12/2025 | Final vesting date of the stock options. |
| 12/12/2034 | Expiration date of the stock options. |
Keywords
stock options, insider trading, Soligenix, SNGX, director, Jerome B. Zeldis, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.